Active substanceChondroitin sulfateChondroitin sulfate
Similar drugsTo uncover
  • Artogistan
    solution w / m 
    GROTEKS, LLC     Russia
  • ARTRA® Chondroitin
    capsules inwards 
    Unipharm, Inc.     USA
  • Arthravir®-Inkamparm®
    solution w / m 
    TRIVIUM-XXI, LLC     Russia
  • Arthradol®
    lyophilizate w / m 
    Inkamfarm, OOO     Russia
  • ARTRADOL®
    capsules inwards 
    TRIVIUM-XXI, LLC     Russia
  • Artrafic
    ointment externally 
    ATOLL, LLC     Russia
  • DRASTOP
    solution w / m 
  • Mukosat®
    solution w / m 
  • Mukosat®
    ointment externally 
       
  • Teraflex® Hondrokrem Forte
    cream externally 
    BAYER, AO     Russia
  • Hondroguard®
    solution w / m 
  • Chondroitin
    capsules inwards 
    VERTEKS, AO     Russia
  • Chondroitin
    gel externally 
    VERTEKS, AO     Russia
  • Chondroitin
    capsules inwards 
    ATOLL, LLC     Russia
  • Chondroitin sulfate
    lyophilizate w / m 
    ELLARA, LTD.     Russia
  • Chondroitin-Akos
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Chondroitin-Akos
    capsules inwards 
    SYNTHESIS, OJSC     Russia
  • Chondroitin sulfate
    solution w / m 
    Medimeks, ZAO     Russia
  • Chondroitin sulfate
    solution w / m 
    ELLARA, LTD.     Russia
  • Chondroitin sulfate
    lyophilizate w / m 
  • Chondroitin sulfate
    solution w / m 
    BIOSINTEZ, PAO     Russia
  • Chondroxide®
    ointment externally 
    NIZHFARM, JSC     Russia
  • Chondroxide®
    pills inwards 
    NIZHFARM, JSC     Russia
  • Chondroxide®
    gel externally 
    NIZHFARM, JSC     Russia
  • Chondrolon®
    lyophilizate w / m 
  • Dosage form: & nbspointment for external use
    Composition:

    For 100 g of ointment:

    Active substance: chondroitin sodium sulfate in terms of dry matter - 5.0 g.

    Excipients: dimethylsulfoxide 10.0 g; Vaseline - 50.0 g; lanolin - 15.0 g; purified water - up to 100.0 g.

    Description:Ointment is light yellow with a characteristic odor.
    Pharmacotherapeutic group:Reparation of tissue stimulant
    ATX: & nbsp

    M.01.A.X.25   Chondroitin sulfate

    Pharmacodynamics:

    Arthrafic stimulates regenerative (regenerative) processes and normalizes metabolism in articular cartilage, has analgesic and anti-inflammatory effect, slows the progression of osteoarthritis and osteochondrosis. Arthrafica contains a natural component chondroitin sulfate (high molecular weight mucopolysaccharide), obtained from the tissues of bovine animals.

    Chondroitin sulfate improves phosphoric-calcium metabolism in the cartilaginous tissue, accelerates the process of its repair, inhibits the processes of degeneration (destruction) of the cartilaginous tissue; prevents the collapse of connective tissue; inhibits enzymes that damage cartilage tissue,stimulates the synthesis of glucosaminoglycans, promotes regeneration (restoration) of the articular bag and cartilage surfaces of joints, increases production intra-articular fluid. This leads to a decrease in soreness and increased mobility of the affected joints.

    Pharmacokinetics:According to the data obtained in experimental studies in mice using radiolabeled 3H-chondroitin sulfate, the chondroitin sulfate absorption index is 14%. Dimethylsulfoxide, which is part of the ointment, promotes better penetration of chondroitin sulfate through cell membranes deep into tissues. Chondroitin sulfate after application of the ointment on the skin enters the joint with reaching the maximum concentration after 30 minutes and the subsequent two-phase excretion of the drug from the cartilage tissue. Completion of the rapid phase of withdrawal occurs 1 hour after application. The retention time of the drug in the joint is 5 hours.
    Indications:Treatment and prevention of osteochondrosis, osteoarthritis of peripheral joints and spine.
    Contraindications:Hypersensitivity to the components of the drug.Violation of the integrity of the skin in places where the drug is supposed to be applied.
    Carefully:Pregnancy, the period of breastfeeding, children under 18 years of age (efficacy and safety not established).
    Dosing and Administration:
    Outer: apply 2-3 times a day on the skin over the lesion and rub for 2-3 minutes until completely absorbed. The course of treatment is 2-3 weeks. If necessary, repeat the course of treatment.
    Side effects:Allergic reactions.
    Overdose:No cases of overdose with arthrafic were reported.
    Interaction:Cases of interaction or incompatibility with other drugs are not described.
    Special instructions:Avoid contact with Artrafic on mucous membranes and open wounds.
    Effect on the ability to drive transp. cf. and fur:Does not affect a patient's ability to engage in potentially hazardous activities requiring increased attention and speed of mental and motor reactions.
    Form release / dosage:Ointment for external use 5%.
    Packaging:

    For 30 or 50 grams of aluminum tubes.

    By 10, 15, 20, 25, 30 or 50 g in cans of dark glass such as BTS made of glass fiber with pull-on lids.The label is self-adhesive on the can. Each tube or jar, together with the instruction for use, is placed in a cardboard package (pack) of cardboard for consumer containers.

    Storage conditions:In the dark place at a temperature of no higher than 20 ° C. Keep out of the reach of children.
    Shelf life:3 years. Do not use after the expiration date.
    Terms of leave from pharmacies:Without recipe
    Registration number:LP-002788
    Date of registration:26.12.2014 / 30.07.2015
    Expiration Date:26.12.2019
    The owner of the registration certificate:ATOLL, LLC ATOLL, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp13.09.2017
    Illustrated instructions
      Instructions
      Up